Royalty Pharma Raises $600 Million of Debt MarketWatch (press release) Leading products in Royalty Pharma's portfolio include: Abbott's Humira(R), Johnson and Johnson's Remicade(R) and Prezista(R), Gilead's Atripla(R), Truvada(R), Complera(R) and Emtriva(R), Pfizer's Lyrica (R), Amgen's Neupogen(R) and Neulasta(R), ...

Eisai launches epilepsy drug Zebinix in Sweden PMLiVE This will put it into competition with more established treatments, like Pfizer's Lyrica (pregabalin) and UCB's Keppra (levetiracetam) and Vimpact (lacosamide) brands. But with up to a third of epilepsy patients not achieving adequate seizure control ...

Hot Topics and Readers' Notes - 05-23-12 ProHealth Note: This study reported that Lyrica reduced average waking time after sleep onset by 19 minutes and average total sleep time by 25.5 minutes - from 6.2 hours to 6.6 hours on average. Many reported some pain reduction too, while about 30% experienced ...

EON: Enhanced Online News (press release) Pfizer Exploratory Study Measures Effects Of Lyrica (pregabalin) On Brain ... EON: Enhanced Online News (press release) NEW YORK--(EON: Enhanced Online News)--Pfizer Inc. (NYSE: PFE) announced today the results of studies on Lyrica  (pregabalin) capsules CV presented at the American Pain Society Annual Meeting in Honolulu. The studies included exploratory research ... Pfizer Reports Results Of Studies On Lyrica Capsules CV - Quick Facts Anti-Epileptic Drugs for Fibromyalgia

Pfizer Exploratory Study Measures Effects Of Lyrica (pregabalin) On Brain ... MarketWatch (press release) NEW YORK, May 18, 2012 (BUSINESS WIRE) -- Pfizer Inc. (NYSE:PFE) announced today the results of studies on Lyrica (R) (pregabalin) capsules CV presented at the American Pain Society Annual Meeting in Honolulu. The studies included exploratory research ... Microsoft and 3 Dow 30 Giants Making Moves

New Lyrica Oral Formulation For Patients With Dysphagia Available In UK Medical News Today Lyrica  (pregabalin) is now available in a new strawberry-flavored oral solution form in the UK, in order to benefit patients who have difficulty in taking medication in capsule form or for those with dysphagia (swallowing difficulty).

Newsday Pfizer halts late-stage study into possible additional use for pain treatment ... Washington Post NEW YORK â Pfizer halted a late-stage study of its second-best selling drug, Lyrica , as a possible treatment for a nerve pain in HIV patients. The world's largest drugmaker said Friday it was studying the drug in patients with HIV neuropathy, ... Pfizer Says Lyrica Fails in Diabetes Trial, Halts HIV Study Pfizer's Lyrica disppointing in diabetes study Lyrica Fails in Pain Trials -

Fox11online.com Pfizer Says Lyrica Fails in Diabetes Trial, Halts HIV Study BusinessWeek By Elizabeth Lopatto and Robert Langreth on May 04, 2012 Pfizer Inc.'s (PFE) (PFE) Lyrica , approved for use in fibromyalgia, didn't work to control painful nerve damage from diabetes in one study, and the company halted a second trial in nerve-damaged ... Pfizer's Lyrica Nerve-Pain Drug Fails To Meet Endpoint In Diabetes Study Pfizer's Lyrica falls short in two pain studies Pfizer's Lyrica Fails In Inadequately Treated PDPN; Trial For New Use Halted - -